NMDP FOUNDATION

EIN: 411704734 501(c)(3) Philanthropy & Grantmaking

MINNEAPOLIS, MN

Total Revenue
$24,304,642
Total Expenses
$22,065,002
Total Assets
$18,372,366
Net Assets
$16,519,630
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1991
Legal Domicile
MN
Principal Officer
ERICA JENSEN
Phone
7634068700
Tax Period
2023-10-01 to 2024-09-30

NMDP FOUNDATION, founded in 1991, is a mid-sized nonprofit in the Philanthropy & Grantmaking sector that reported $24.3M in total revenue in fiscal year 2023. Revenue surged 30% from the prior year, signaling strong growth momentum. Expenses of $22.1M left a modest 9% surplus.

Mission

OTHER GAMING MANAGER INCLUDES AMANDA ALBERTSON, WHO OBTAINS LICENSES AND MANAGES THE PLANNING AND EXECUTION OF RAFFLES.

Program Service Accomplishments

Program 1
Expenses: $6,639,306 Revenue: $0

PATIENT ASSISTANCE:THE NMDP FOUNDATION PROVIDES FINANCIAL ASSISTANCE TO PATIENTS THROUGHOUT EACH STAGE OF THE TRANSPLANT PROCESS. FUNDED BY PHILANTHROPY, IN FY24, MORE THAN $6.3 MILLION WAS PROVIDED...

Read more

PATIENT ASSISTANCE:THE NMDP FOUNDATION PROVIDES FINANCIAL ASSISTANCE TO PATIENTS THROUGHOUT EACH STAGE OF THE TRANSPLANT PROCESS. FUNDED BY PHILANTHROPY, IN FY24, MORE THAN $6.3 MILLION WAS PROVIDED TO OVER 3,300 PATIENTS FROM 160 TRANSPLANT CENTERS. IN FY24, THE PROPORTION OF GRANT RECIPIENTS WHO IDENTIFIED AS NON-HISPANIC WHITE RANGED FROM 0%-66% DEPENDING ON THE GRANT TYPE. FOR THE SICKLE CELL FERTILITY PRESERVATION GRANT, WHICH HELPS PAY FOR FERTILITY PRESERVATION AND STORAGE PRE-TRANSPLANT FOR SICKLE CELL DISEASE, ALL RECIPIENTS IDENTIFIED AS EITHER BLACK OR AFRICAN AMERICAN. FOR THE POST-TRANSPLANT SUPPORT ASSISTANCE (TSA) GRANT, 66% OF RECIPIENTS IDENTIFIED AS NON-HISPANIC WHITE. THE SEARCH ASSISTANCE FUND GRANT (SAF) SUPPORT PATIENTS PRE-TRANSPLANT WHO HAVE BARRIERS RELATED TO INSURANCE THAT DELAY OR PREVENT THEM FROM FINDING A DONOR OR CORD BLOOD UNIT. THIS GRANT HELPS PATIENTS START THE SEARCH FOR AN UNRELATED DONOR OR CORD BLOOD UNIT BY GIVING TRANSPLANT CENTERS A GUARANTEE OF PAYMENT FOR SPECIFIC SEARCH AND/OR PROCUREMENT COSTS SHOULD THEY NOT BE COVERED BY INSURANCE. THERE WERE 6 PATIENTS APPROVED FOR SAF IN FY24.THE SICKLE CELL FERTILITY PRESERVATION GRANT HELPS PAY FOR FERTILITY PRESERVATION AND STORAGE FEES FOR PATIENTS WITH SICKLE CELL DISEASE PREPARING FOR TRANSPLANT. THIS GRANT IS PAID TO THE FERTILITY PRESERVATION CLINIC OR PATIENT WHEN INSURANCE DOES NOT COVER THIS COST. IN FY24, THIS GRANT WAS DISTRIBUTED TO 15 PATIENTS WITH AN AVERAGE AWARD AMOUNT OF $4,680. NMDP ALSO PROVIDES FUNDING TO HELP WITH THE MANY UNCOVERED OUT-OF-POCKET EXPENSES FOR PATIENTS BEFORE AND AFTER TRANSPLANT. THE TSA GRANT PROVIDES DIRECT FINANCIAL ASSISTANCE TO QUALIFIED FAMILIES BOTH PRE- AND POST-TRANSPLANT. TSA HELPS WITH EXPENSES SUCH AS TRANSPORTATION, TEMPORARY RELOCATION, COPAYS AND INSURANCE PREMIUMS. IN FY24, 3,337 TSA AWARDS WERE GRANTED TO 2,649 PATIENTS PRE- AND POST-TRANSPLANT WITH THE AVERAGE AWARD BEING $1,418.THE JOHN AND CARYN CAMIOLO SURVIVORSHIP GRANT (CAM) PROVIDES DIRECT FINANCIAL ASSISTANCE TO ELIGIBLE PATIENTS, WHO ARE AT LEAST THREE MONTHS POST-TRANSPLANT AND WHO ARE ACTIVELY RECEIVING TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE. CAM HELPS WITH UNCOVERED COSTS OF TREATMENT AND PRESCRIPTIONS. IN FY24, 206 PATIENTS WERE HELPED THROUGH THE CAM GRANT WITH EACH PATIENT AWARDED $750.THE CHELL TRAVEL GRANT PROVIDES DIRECT FINANCIAL ASSISTANCE TO ELIGIBLE PATIENTS WHO NEEDED ASSISTANCE WITH TRAVEL COSTS TO PARTICIPATE IN CLINICAL TRIALS THAT TREAT BLOOD CANCERS OR BLOOD DISORDERS. FOR THIS GRANT, 41% OF RECIPIENTS IDENTIFIED AS NON-HISPANIC WHITE. IN FY24, 204 PATIENTS RECEIVED THE CHELL TRAVEL GRANT WITH THE AVERAGE AWARD AMOUNT BEING $1,485.TWO CRISIS GRANTS HELP PATIENTS EXPERIENCING A SIGNIFICANT CRISIS EVENT IMPACTING ACCESS TO TRANSPLANT OR POST-TRANSPLANT CARE. THE IRA AND DIANA RIKLIS CRISIS GRANT PROVIDES UP TO $10,000 IN DIRECT FINANCIAL ASSISTANCE TO QUALIFIED PATIENTS POST-TRANSPLANT AND THE MAKE ME STRONGER CRISIS GRANT PROVIDES UP TO $15,000 PRE-TRANSPLANT. IN FY24, 47 PATIENTS WERE HELPED THROUGH THESE CRISIS GRANTS WITH THE AVERAGE AWARD AMOUNT BEING $8,842. A COMMITTEE OF BMT SOCIAL WORKERS AND NAVIGATORS REVIEWS EACH CRISIS APPLICATION TO ENSURE EQUITABLE DISTRIBUTION OF THIS GRANT. IN FY24, 47% OF GRANT RECIPIENTS IDENTIFIED AS NON-HISPANIC WHITE.

Program 2
Expenses: $2,306,006 Revenue: $0

RECRUITMENT:THE NMDP REGISTRY IS THE MOST DIVERSE LISTING OF POTENTIAL DONORS AND CORD BLOOD UNITS IN THE WORLD. EVERY SEARCH THROUGH NMDP PROVIDES PATIENTS WITH ACCESS TO MORE THAN 44 MILLION...

Read more

RECRUITMENT:THE NMDP REGISTRY IS THE MOST DIVERSE LISTING OF POTENTIAL DONORS AND CORD BLOOD UNITS IN THE WORLD. EVERY SEARCH THROUGH NMDP PROVIDES PATIENTS WITH ACCESS TO MORE THAN 44 MILLION POTENTIAL ADULT DONORS AND MORE THAN 820,000 CORD BLOOD UNITS WORLDWIDE. THE BEST MATCH FOR A PATIENT IS TYPICALLY SOMEONE WHO SHARES THEIR ETHNIC BACKGROUND. IMPROVING THE ETHNIC DIVERSITY OF THE NMDP REGISTRY IMPROVES ALL PATIENTS' ODDS OF FINDING THEIR BEST MATCH, REGARDLESS OF ETHNIC BACKGROUND.PEOPLE BETWEEN THE AGES OF 18 AND 30 ARE MOST URGENTLY NEEDED. RESEARCH HAS SHOWN THAT CELLS FROM YOUNGER DONORS LEAD TO BETTER LONG-TERM SURVIVAL FOR PATIENTS.IN FY24, MORE THAN 240,000 POTENTIAL DONORS JOINED THE NMDP REGISTRY AND MORE THAN 4,400 UMBILICAL CORD UNITS WERE ADDED TO THE REGISTRY.

Program 3
Expenses: $1,983,699 Revenue: $0

RESEARCH: RESEARCH INNOVATIONS ARE CRITICAL TO EXPANDING TREATMENT TO MORE PATIENTS AND IMPROVING OUTCOMES. EACH YEAR, THE NMDP FOUNDATION IS PROUD TO INVEST IN RESEARCH THROUGH:THE NMDP AMY STRELZER...

Read more

RESEARCH: RESEARCH INNOVATIONS ARE CRITICAL TO EXPANDING TREATMENT TO MORE PATIENTS AND IMPROVING OUTCOMES. EACH YEAR, THE NMDP FOUNDATION IS PROUD TO INVEST IN RESEARCH THROUGH:THE NMDP AMY STRELZER MANASEVIT RESEARCH PROGRAM: THE AMY PROGRAM FUNDS EARLY CAREER INVESTIGATORS FOCUSED ON ADVANCES IN THE PREVENTION AND TREATMENT OF POST-CELL THERAPY COMPLICATIONS (E.G., GRAFT-VERSUS-HOST -DISEASE AND INFECTION).IN 2024, WE FUNDED THE WORK OF 14 AMY SCHOLARS. AMY SCHOLARS HAVE GONE ON TO BECOME LEADERS IN THE FIELD, PURSUING SCIENTIFIC ADVANCES THAT HELP NMDP PATIENTS LIVE LONGER, HEALTHIER LIVES. SINCE 1998, THE NMDP FOUNDATION HAS INVESTED NEARLY $12.5 MILLION TO HELP LAUNCH THE CAREERS OF 51 YOUNG PHYSICIAN-SCIENTISTS. AFTER RECEIVING THEIR NMDP AMY SCHOLAR AWARD, 51 YOUNG PHYSICIAN-SCIENTISTS HAVE GONE ON TO WIN MORE THAN $250 MILLION IN SUBSEQUENT GOVERNMENT GRANT FUNDING TO PURSUE THE DISCOVERIES TO HELP PATIENTS LIVE LONGER, HEALTHIER LIVES AFTER CELL THERAPY. TODAY, THE AMY STRELZER MANASEVIT RESEARCH PROGRAM FOR THE STUDY OF POST-CELL THERAPY COMPLICATIONS IS ONE OF THE LARGEST AND MOST COVETED FELLOWSHIPS IN THE FIELD OF TRANSPLANTATION.NMDP DONOR FOR ALL: THIS SERIES OF TRANSFORMATIONAL MULTI-CENTER CLINICAL TRIALS ARE TESTING A NEW TRANSPLANT PROTOCOL AIMED AT MAKING MISMATCHED DONOR TRANSPLANTS SAFER AND MORE EFFECTIVE, WITH THE GOAL OF EXPANDING ACCESS TO TRANSPLANT TO THOUSANDS OF PATIENTS WHO LACK A FULLY MATCHED DONOR.ANTHONY NOLAN TRUST: PROVIDE SUPPORT TO THE ANTHONY NOLAN RESEARCH INSTITUTE TO CONTINUE DEVELOPMENT AND MAINTENANCE OF AN HLA CLASS I AND II SEQUENCE DATABASE AND PROVISION OF HLA CLASS I AND II SEQUENCE INFORMATION.CIBMTR (THE CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH) A PARTNERSHIP BETWEEN THE MEDICAL COLLEGE OF WISCONSIN AND NMDP IS THE LEADING HUB FOR TRANSPLANT AND CELL THERAPY RESEARCH. THE NMDP FOUNDATION HELPS TO FUND VARIOUS OTHER INNOVATIVE RESEARCH STUDIES LED AND MANAGED BY THE CIBMTR.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $22,907,977
Program Service Revenue $0
Investment Income $2,335,205
Other Revenue $-938,540
TOTAL REVENUE $24,304,642

Expense Breakdown

Grants Paid $12,389,221
Salaries & Benefits $7,240,574
Fundraising Expenses $2,175,120
Program Expenses $18,126,967
Other Expenses $1,952,631
TOTAL EXPENSES $22,065,002

Year-over-Year Comparison

2023 2022 Change
Revenue $24,304,642 $18,688,988 +0.3%
Expenses $22,065,002 $18,261,426 +0.2%
Net Income $2,239,640 $427,562 +4.2%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
17
Independent Members
16
Employees
45
Volunteers
3000

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
7
$2,696,698
Total Directors
17
$1,993,701
Key Employees
1
$744,100
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
AMY RONNEBERG NMDP CHIEF EXECUTIVE OFFICER 2.00
Officer Director
$0 $455,038 $1,993,701
MICHAEL STEWART CHAIR 1.00
Officer Director
$0 $0 $0
MELISSA KONG VICE CHAIR 1.00
Officer Director
$0 $0 $0
RAMESH SUBRAHMANIAN SECRETARY 1.00
Officer Director
$0 $0 $0
DIANNA CERVANTES TREASURER 1.00
Officer Director
$0 $0 $0
JASON AHLGREN DIRECTOR 1.00
Director
$0 $0 $0
GUSTAVO ALCOCER DIRECTOR 1.00
Director
$0 $0 $0
SARAH ASMA DIRECTOR 1.00
Director
$0 $0 $0
ANDREW BLOCK DIRECTOR 1.00
Director
$0 $0 $0
BILL FURLONG DIRECTOR 1.00
Director
$0 $0 $0
SULEIKA JAOUAD DIRECTOR 1.00
Director
$0 $0 $0
BRUCE MANASEVIT DIRECTOR 1.00
Director
$0 $0 $0
JOHN PRESLEY DIRECTOR 1.00
Director
$0 $0 $0
DERYN POMEROY DIRECTOR 1.00
Director
$0 $0 $0
RAYNE ROUCE DIRECTOR 1.00
Director
$0 $0 $0
MELODY SMITH DIRECTOR 1.00
Director
$0 $0 $0
REBECCA WENNGATZ DIRECTOR 1.00
Director
$0 $0 $0
KRISTA DUSIL CHIEF FINANCIAL OFFICER (THRU 2/24) 1.00
Officer
$0 $53,242 $702,997
KATHERINE HEYERDAHL CHIEF FINANCIAL OFFICER (BEGAN 4/24) 2.00
Officer
$0 $0 $0
JOY KING CHIEF ADVANCEMENT OFFICER 20.00
Key Emp
$230,187 $168,631 $744,100
TODD PETERSON VICE PRESIDENT, ADVANCEMENT 50.00
Highest
$291,111 $84,039 $375,150
ANGIE FITZGERALD VP, CORPORATE & FOUNDATION PARTNERSHIPS 50.00
Highest
$274,522 $64,855 $339,377
ALEX MENSING SR. DIRECTOR, SUPPORTER EXPERIENCE & ENGAGEMENT 50.00
Highest
$199,924 $46,470 $246,394
DANIEL LEE DIRECTOR, MAJOR AND PLANNED GIFTS 50.00
Highest
$190,612 $32,174 $222,786
KEVIN HEALY DIRECTOR, ADVANCEMENT SERVICES 50.00
Highest
$182,633 $42,949 $225,582
GINA GRAVES FORMER OFFICER 0.00
$0 $3,353 $243,311
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $24,304,642 $22,065,002 $18,372,366 $2,239,640
2023 $18,688,988 $18,261,426 $15,913,956 $427,562
2023 $18,688,988 $18,261,426 $15,913,956 $427,562
2022 $12,801,747 $17,777,670 $15,501,279 $-4,975,923
2021 $21,167,274 $13,533,546 $21,284,478 $7,633,728
2020 $18,274,388 $13,464,647 $17,220,560 $4,809,741
2019 $11,079,088 $16,917,992 $16,248,451 $-5,838,904
2018 $11,686,167 $13,940,845 $15,117,948 $-2,254,678
Explore More Nonprofits
Top 100 Nonprofits in Minnesota Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare NMDP FOUNDATION with other nonprofits in Minnesota and across the country.